Silk Road Medical Stock Earnings Per Share
SILKDelisted Stock | USD 27.49 0.00 0.00% |
Silk Road Medical fundamentals help investors to digest information that contributes to Silk Road's financial success or failures. It also enables traders to predict the movement of Silk Stock. The fundamental analysis module provides a way to measure Silk Road's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Silk Road stock.
Silk |
Silk Road Medical Company Earnings Per Share Analysis
Silk Road's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Silk Road Earnings Per Share | (1.45) X |
Most of Silk Road's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Silk Road Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Silk Road Medical has an Earnings Per Share of -1.45 times. This is 117.32% lower than that of the Health Care Equipment & Supplies sector and notably lower than that of the Health Care industry. The earnings per share for all United States stocks is 146.47% higher than that of the company.
Silk Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Silk Road's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Silk Road could also be used in its relative valuation, which is a method of valuing Silk Road by comparing valuation metrics of similar companies.Silk Road is currently under evaluation in earnings per share category among its peers.
Silk Fundamentals
Return On Equity | -0.36 | |||
Return On Asset | -0.14 | |||
Profit Margin | (0.30) % | |||
Operating Margin | (0.34) % | |||
Current Valuation | 1.02 B | |||
Shares Outstanding | 40.63 M | |||
Shares Owned By Insiders | 4.15 % | |||
Shares Owned By Institutions | 97.46 % | |||
Number Of Shares Shorted | 3.15 M | |||
Price To Book | 7.22 X | |||
Price To Sales | 5.83 X | |||
Revenue | 177.13 M | |||
Gross Profit | 100.76 M | |||
EBITDA | (55.48 M) | |||
Net Income | (55.74 M) | |||
Cash And Equivalents | 108.87 M | |||
Cash Per Share | 3.09 X | |||
Total Debt | 84.63 M | |||
Debt To Equity | 1.37 % | |||
Current Ratio | 6.92 X | |||
Book Value Per Share | 3.81 X | |||
Cash Flow From Operations | (32.01 M) | |||
Short Ratio | 2.48 X | |||
Earnings Per Share | (1.45) X | |||
Price To Earnings To Growth | (0.26) X | |||
Target Price | 20.75 | |||
Number Of Employees | 474 | |||
Beta | 1.54 | |||
Market Capitalization | 1.12 B | |||
Total Asset | 265.31 M | |||
Retained Earnings | (399.45 M) | |||
Working Capital | 210.55 M | |||
Net Asset | 265.31 M |
About Silk Road Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Silk Road Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Silk Road using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Silk Road Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Silk Stock
If you are still planning to invest in Silk Road Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silk Road's history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |